SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-16-006584
Filing Date
2016-03-15
Accepted
2016-03-15 16:03:10
Documents
56
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT opxa_10k.htm 10-K 1251097
2 AMENDED AND RESTATED SERIES N WARRANTS ex413.htm EX-4.13 156940
3 AMENDMENT TO STOCK PURCHASE AGREEMENT ex_1021.htm EX-10.21 22910
4 OFFER LETTER ex_1022.htm EX-10.22 135740
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_231.htm EX-23.1 3090
6 CERTIFICATION ex_311.htm EX-31.1 17102
7 CERTIFICATION ex_312.htm EX-31.2 17159
8 CERTIFICATION ex_321.htm EX-32.1 9274
9 CERTIFICATION ex_322.htm EX-32.2 9748
10 opximg.jpg GRAPHIC 2479
  Complete submission text file 0001354488-16-006584.txt   3430938

Data Files

Seq Description Document Type Size
11 opxa-20151231.xml EX-101.INS 320919
12 opxa-20151231.xsd EX-101.SCH 40052
13 opxa-20151231_cal.xml EX-101.CAL 39015
14 opxa-20151231_def.xml EX-101.DEF 55321
15 opxa-20151231_lab.xml EX-101.LAB 256389
16 opxa-20151231_pre.xml EX-101.PRE 161347
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33004 | Film No.: 161506895
SIC: 2834 Pharmaceutical Preparations